COVID-19 Resurges in Seychelles, world’s most vaccinated nation: Raises question of Chinese vaccine efficacy


The small island of Seychelles has the distinction of being the most vaccinated country in the world. However, that title rings hollow as there is a huge resurgence of coronavirus in the tiny island archipelago. The Wall Street Journal has reported that the daily case rate is very high. The nation has “a higher number of infections per capita than India.” Currently, India is also facing a huge resurgence in COVID-19 infections, hospitalizations, and deaths. Most of the island residents were vaccinated with the Chinese vaccine, Sinopharm.


According to the latest reports about 67 percent of the island’s population is vaccinated. A majority of them received the Chinese vaccine, Sinopharm, while the rest received Covishield which is Astra Zeneca vaccine developed by SII in India.


The Health Ministry in Seychelles said that more than 34 percent of new active cases have been found among those who were fully vaccinated. The WSJ said that the situation was being watched all over the world for what it said about the effectiveness of vaccines. The island authorities have not revealed how many of these new cases had received the Sinopharm vaccine.


The Seychelles government has recently put forth COVID-19 protocols. These measures have been instituted to prevent the further spread of infections. Some of these measures include closing the island’s bars early and preventing households from intermingling. Schools have also been closed. Sporting activities have also been canceled for at least two weeks while the tiny nation grapples with the new wave of infections.


There is some good news according to Kate O’ Brien who is a director of immunizations, vaccines and biologicals at the World Health Organization (WHO). She said that the Sinopharm vaccine required two doses. Some of the cases were occurring after the first dose and “soon after a second dose.” Incidentally on Friday, the World Health Organization had cleared the Sinopharm vaccine for emergency, global use, although there is minimal data on its efficacy in patients over the age of 60.


Other nations such as the U.K. (52 percent have taken at least one dose) has seen its cases plunge by 96 percent since the last high infection rate in January and Israel (60 percent have taken at least one dose) saw a much steeper fall of 99 percent

Follow us on Google news for more updates and News


This content is being provided to you for informational purposes only. The content has been prepared by third parties not affiliated with CWEB Inc, a business. This content and any information contained therein, does not constitute a recommendation by CWEB to buy, sell or hold any security, financial product or instrument referenced in the content. This information neither is, nor should be construed as an offer, or a solicitation of an offer, to buy or sell securities by CWEB Inc. CWEB Inc. does not offer or provide any opinion regarding the nature, potential, value, suitability or profitability of any particular investment or investment strategy, and you shall be fully responsible for any investment decisions you make, and such decisions will be based solely on your evaluation of your financial circumstances, investment objectives, risk tolerance, and liquidity needs.

Unless stated otherwise, the web content provided by the CWEB family of companies is for educational purposes only. The information and tools provided neither are, nor should be construed, as an offer, or a solicitation of an offer, to buy or sell securities by CWEB Inc. or its affiliates. Unless stated otherwise, no information presented constitutes a recommendation by CWEB Inc. or its affiliates to buy, sell or hold any security, financial product or instrument discussed therein or to engage in any specific investment strategy.

Full Disclaimer